Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-16.56%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$3.87B
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,022
New
308
Increased
1,176
Reduced
1,104
Closed
401
Top Buys
| 1 |
Netflix
NFLX
|
+$324M |
| 2 |
Altria Group
MO
|
+$252M |
| 3 |
JPMorgan Chase
JPM
|
+$251M |
| 4 |
Meta Platforms (Facebook)
META
|
+$247M |
| 5 |
Intel
INTC
|
+$245M |
Top Sells
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$284M |
| 3 |
S&P Global
SPGI
|
+$238M |
| 4 |
Eli Lilly
LLY
|
+$213M |
| 5 |
Amazon
AMZN
|
+$188M |
Sector Composition
| 1 | Technology | 24.16% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.46% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Voyager Therapeutics
VYGR
$231M
| $181K | ﹤0.01% |
30,700
+17,200
| +127% | +$101K |
|
2302
XBiotech
XBIT
$85.4M
| $179K | ﹤0.01% |
+31,800
| New | +$179K |
|
|
SIEN
2303
DELISTED
Sientra, Inc.
SIEN
| $178K | ﹤0.01% |
21,230
+1,920
| +10% | +$16.1K |
|
2304
Synlogic
SYBX
$17.5M
| $177K | ﹤0.01% |
10,253
-827
| -7% | -$14.3K |
|
2305
Interface
TILE
$1.6B
| $177K | ﹤0.01% |
14,100
-13,400
| -49% | -$168K |
|
2306
Arbutus Biopharma
ABUS
$886M
| $175K | ﹤0.01% |
64,400
-171,800
| -73% | -$467K |
|
2307
Millicom
TIGO
$8.01B
| $172K | ﹤0.01% |
+12,000
| New | +$172K |
|
|
LRFC
2308
DELISTED
Logan Ridge Finance Corp
LRFC
| $169K | ﹤0.01% |
10,721
-7,900
| -42% | -$125K |
|
|
RDBX
2309
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
| $169K | ﹤0.01% |
+22,900
| New | +$169K |
|
2310
Dyne Therapeutics
DYN
$1.89B
| $167K | ﹤0.01% |
24,300
-24,200
| -50% | -$166K |
|
|
HMTV
2311
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $167K | ﹤0.01% |
+21,900
| New | +$167K |
|
2312
Ambac
AMBC
$415M
| $166K | ﹤0.01% |
14,600
-22,800
| -61% | -$259K |
|
2313
Shattuck Labs
STTK
$83.8M
| $166K | ﹤0.01% |
40,800
-44,200
| -52% | -$180K |
|
|
VNET
2314
VNET Group
VNET
$2.13B
| $164K | ﹤0.01% |
27,200
+900
| +3% | +$5.43K |
|
|
FCRD
2315
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $162K | ﹤0.01% |
45,668
-5,400
| -11% | -$19.2K |
|
2316
ESSA Pharma
EPIX
$9.7M
| $161K | ﹤0.01% |
51,100
-61,900
| -55% | -$195K |
|
2317
Riverview Bancorp
RVSB
$101M
| $161K | ﹤0.01% |
24,400
-12,800
| -34% | -$84.5K |
|
2318
Cato Corp
CATO
$89.6M
| $160K | ﹤0.01% |
13,800
-800
| -5% | -$9.28K |
|
|
GTHX
2319
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $158K | ﹤0.01% |
32,000
-50,200
| -61% | -$248K |
|
|
CTHR
2320
DELISTED
Charles & Colvard Ltd
CTHR
| $158K | ﹤0.01% |
12,970
-1,600
| -11% | -$19.5K |
|
|
BNR
2321
Burning Rock Biotech
BNR
$95.5M
| $157K | ﹤0.01% |
+5,400
| New | +$157K |
|
|
CKPT
2322
DELISTED
Checkpoint Therapeutics
CKPT
| $156K | ﹤0.01% |
15,100
-10,470
| -41% | -$108K |
|
2323
Protara Therapeutics
TARA
$120M
| $156K | ﹤0.01% |
53,118
-12,800
| -19% | -$37.6K |
|
|
STSA
2324
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $156K | ﹤0.01% |
37,600
-29,000
| -44% | -$120K |
|
2325
Tarsus Pharmaceuticals
TARS
$2.29B
| $155K | ﹤0.01% |
+10,600
| New | +$155K |
|